STEVEN NEUS

Allopathic & Osteopathic Physicians|Family Medicine FOSTER, KY NPI 1801895396

General Payments — all program years on this page

$2,864.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 166
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $335.59 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $335.5918

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $226.2017
2019 $77.056
2020 $235.8216
2021 $906.3149
2022 $652.5234
2023 $430.7726
2024 $335.5918

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086249868 Bayer Healthcare Pharmaceuticals Inc. $22.07 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096870715 Novo Nordisk Inc $13.70 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105112998 ABBVIE INC. $15.48 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105113000 ABBVIE INC. $20.37 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105654342 AstraZeneca Pharmaceuticals LP $13.10 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114807450 Exact Sciences Corporation $16.92 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117639843 Amgen Inc. $21.14 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125282018 Abbott Laboratories $22.63 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133742593 Gilead Sciences, Inc. $22.47 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133914207 Vanda Pharmaceuticals Inc. $21.11 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137642898 Takeda Pharmaceuticals U.S.A., Inc. $17.42 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137642900 Takeda Pharmaceuticals U.S.A., Inc. $14.19 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139353861 Astellas Pharma US Inc $20.22 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148322876 Axsome Therapeutics, Inc. $30.21 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153518492 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.14 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153653816 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.14 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153686812 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.14 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153689678 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.14 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.